Strength
10 mg/1
Manufacturer
Micro Labs LimitedNDC
42571027560
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
DALFAMPRIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA210158On Market Since
3/21/2019
Pharmacological Classes
Potassium Channel Antagonists
Potassium Channel Blocker
Related Drugs
Same classification
REPAGLINIDE 1 MG TABLET
Generic
33342024911•Macleods Pharmaceuticals Limited
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
57237015801•Rising Pharma Holdings Inc.
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
60687056021•American Health Packaging
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
62135094790•Chartwell RX LLC
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
65862067101•Aurobindo Pharma Limited
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
72603081101•NorthStar Rx LLC
$0.0811
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
33342024811•Macleods Pharmaceuticals Limited
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
57237015701•Rising Pharma Holdings Inc.
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
62135094690•Chartwell RX LLC
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
65862067001•Aurobindo Pharma Limited
$0.0812
per EA